New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

Recent studies show GLP-1s tied higher osteoporosis risk, with variations by diabetes status and weight changes in large patient datasets.

People who take GLP-1 medications for several years may face a higher risk of developing osteoporosis, gout, and osteomalacia, according to new research presented Monday at the an ...

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including osteoporosis and gout.

GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better ...

A new research study has shed light on potential side effects of GLP-1 drugs, including Wegovy and Ozempic. According to a ...

An AI tool could flag patients at risk for osteoporosis or osteopenia by evaluating standard hip and pelvis x-rays, new ...

Research links regular exercise to better bone density. Scientists found that people who were more sedentary were less likely to have good bone density. Doctors generally recommend a specific exercise ...

UNIVERSITY PARK, Pa. (KDKA) -- Eating prunes daily may preserve bone density and strength in older women, according to a new study led by Penn State researchers. The study, published in Osteoporosis ...

New research suggests popular GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro may raise the risk of osteoporosis and gout. A large five-year study found slightly higher rates of bone ...